Pharvaris raises $201.2M in funding to advance deucrictibant for HAE treatment, aiming to address unmet needs in the market while enhancing shareholder value.
Amount Raised
$201 Million
Round Type
Funding Round
ZugBiotechnologyHealth CareTherapeuticsInvestors
Description
Pharvaris N.V. has secured $201.2 million in a recent funding round aimed at advancing deucrictibant, a novel oral therapy for hereditary angioedema. This funding will support ongoing clinical trials and the development of dual-action treatment options. The company is positioned to lead in addressing critical gaps in HAE treatment
Quick answer
Pharvaris raised $201 Million in a Funding Round round, dated July 25, 2025. Investors: Leerink Partners. Pharvaris is based in Zug, Zug, Switzerland.
- How much did Pharvaris raise?
- Pharvaris raised $201 Million in a Funding Round round on July 25, 2025.
- Who invested in Pharvaris?
- Leerink Partners is named as investors in this round.
- What does Pharvaris do?
- Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients.
- Where is Pharvaris based and how big is it?
- Pharvaris is based in Zug, Zug, Switzerland. Fundz records about 126 employees.
- Who are the decision-makers at Pharvaris?
- Fundz holds 1 contact at Pharvaris. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Pharvaris that raised within 45 days of this round, from Fundz verified event records.
- Integra Therapeutics raised $13M (Funding Round) on September 8, 2025.
- NRG Therapeutics raised $67M (Funding Round) on September 8, 2025.
- MRM Health raised $64M (Series B) on September 4, 2025.
- Os Therapies raised $3.8M on September 2, 2025.
- TNF Pharmaceuticals raised $7M on September 2, 2025.
- Immuneering raised $25M on August 26, 2025.
Who to call at Pharvaris, and when
A new round usually means Pharvaris is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pharvaris raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pharvaris, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pharvaris. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pharvaris raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pharvaris raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.